会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • DIRECT AND BIOCHEMICALLY FUNCTIONAL DETECTION PROCESS OF RETROVIRUS IN BIOLOGICAL SAMPLES
    • 方法直接和生化功能检测逆转录病毒的生物样品
    • WO1994028115A1
    • 1994-12-08
    • PCT/DE1994000610
    • 1994-05-31
    • FAFF, Ortwin
    • C12N07/02
    • C12N7/00C12N2740/10051C12Q1/48C12Q1/702C12Q1/703Y10S435/961Y10S435/968Y10S435/974
    • A routine, direct and biochemically functional process is disclosed for detecting retrovirus in biological samples. For that purpose, structure-specific extraction with immobilised ligands directed against the viral surface is combined with function-specific enzyme reaction for retrovirus by means of reverse transcriptase, RNAse H, integrase or protease. Reverse transcription by means of reverse transcriptase, retroviral RNA and tRNA is particularly suitable for the retrovirus-specific enzyme reaction. In an ulterior detection step, the newly synthesised cDNA products are identified by radioactive, photometric, luminescent or fluorescent processes. This process represents a biochemical simulation of the natural process of retroviral infection and development within the cell (reverse transcription, integration, maturation) and allows several retroviral components, surface glycoproteins, enzymes, structural proteins, RNA and tRNA to be simultaneously detected. A process with a qualitatively improved specificity compared with state-of-the-art processes is thus obtained. The process takes 1-2 days, may be easily and routinely carried out in a microtiter format and thus allows many probes to be simultaneously processed within a short time. In addition, the process may be universally applied to all species of retrovirus by means of corresponding specific ligands. The process is suitable for detecting retrovirus for the purpose of diagnosing, following and treating viral diseases, in transfusion and transplantation medicine, in virological research and development and for the biological quality control of pharmaceutical and biotechnological products.
    • 所描述的方法允许生物样品中的逆转录病毒的常规直接和生物化学功能周志武检测。 这是通过一个特定的结构提取与固定针对病毒表面配体与逆转录酶,RNA酶H,整合酶,或蛋白酶的反转录病毒的装置的后续功能特定的酶反应相结合来实现。 对于逆转录病毒特异性酶反应,特别是反转录,在逆转录酶,逆转录病毒RNA和tRNA参与。 在随后的检测步骤中,新合成的cDNA产物通过放射性,光度,发光或荧光的方法鉴定。 此方法是生化模仿在细胞中逆转录病毒感染和其处理的自然过程(逆转录,集成,成熟)和允许几个逆转录病毒组分的同时检测等的表面糖蛋白,酶,结构蛋白,RNA和tRNA。 这也提供了比以前的方法,该方法的质量更好的特异性保证。 该过程需要约1-2天可在微量滴定格式容易且常规地进行,使许多样品的同时处理在短时间内。 此外,使用相应的特异性配体的方法是普遍适用于逆转录病毒的所有物种。 该方法适用于诊断,当然和病毒疾病的治疗的逆转录病毒检测在其中输血和移植医学,在病毒学研究和开发以及医药和生物技术产品的生物质量控制。